Sign in
CINC Stock Price, Chart, Stats & News
CinCor Pharma, Inc.
Save
CinCor Pharma, Inc. (CINC) does not currently pay a dividend.
1.27B
Market cap
–
Current P/E
–
Forward P/E
CINC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 0.04% |
ROA | -35.68% |
ROE | 110.68% |
D/E | – |
Interest coverage ratio | – |
CINC valuation
P/E | – |
P/S | – |
P/B | -16.15x |
P/CF | -33.37x |
P/FCF | -41.23x |
P/OCF | -33.37x |
PEG | -0.20x |
EV multiple | -40.67x |
About
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases.
Similar securities
Based on sector and market capitalization
Report issue